Pharmacists in Forks, WA Accepting Medicare
7 Pharmacists found. Showing 1 - 7
 Angelique Williams, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 530 Bogachiel Way, Forks, WA 98331 Phone: 360-374-6271 |
Tytti Sinikka Lilja-williams Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 411 Terra Eden St Apt 8, Forks, WA 98331 Phone: 360-640-1596 |
 Mr. Charles Edward Carlson, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 11 S Forks Ave, Forks, WA 98331 Phone: 360-374-2294 Fax: 360-374-5057 |
Mr. Stanley Oscar Peterson, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 11 S Forks Ave, Forks, WA 98331 Phone: 360-374-5111 |
Ms. Linda A Peterson, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 11 S Forks Ave, Forks, WA 98331 Phone: 360-374-5111 |
Bailey Mae Powers Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 11 S Forks Ave, Forks, WA 98331 Phone: 360-374-2294 |
Mr. Gregory Michael Smith, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 11 S Forks Ave, Forks, WA 98331 Phone: 360-374-2294 |
News Archive
Nanoscopic findings may lead to new experimental methods for early multiple sclerosis diagnosis
Laboratory studies by chemical engineers at UC Santa Barbara may lead to new experimental methods for early detection and diagnosis - and to possible treatments - for pathological tissues that are precursors to multiple sclerosis and similar diseases.
Expansion of HIV screening worthwhile
According to researchers, screening for the AIDS virus to include every American at least once and the highest-risk people once a year could prevent more than 80,000 infections over the next 20 years. The team from Yale University in Connecticut and Stanford University in California reported that if treatment for infected people were integrated into such a program, it would prevent an estimated 212,000 new infections.
Healthier lifestyle associated with lower risk of cognitive impairment for oldest adults
A new analysis of adults aged 80 years and older shows that a healthier lifestyle is associated with a lower risk of cognitive impairment, and that this link does not depend on whether a person carries a particular form of the gene APOE.
KalVista begins Phase I trial of novel plasma kallikrein inhibitor for treatment of DME
KalVista Pharmaceuticals, an ophthalmology company with a focus on diabetic macular edema (DME), today announces that it has begun a Phase I, First in Human, trial of its novel plasma kallikrein inhibitor, KVD001, for the treatment of DME.
› Verified 2 days ago
Counselors
Pharmacists
Dentists
Psychologists
Clinical Social Workers
Occupational Therapists